Endocannabinoids and Traumatic Brain Injury

@article{Mechoulam2007EndocannabinoidsAT,
  title={Endocannabinoids and Traumatic Brain Injury},
  author={Raphael Mechoulam and Esther Shohami},
  journal={Molecular Neurobiology},
  year={2007},
  volume={36},
  pages={68-74}
}
In response to traumatic brain injury, there is local and transient accumulation of 2-AG at the site of injury, peaking at 4 h and sustained up to at least 24 h. Neuroprotection exerted by exogenous 2-AG suggests that the formation of 2-AG may serve as a molecular regulator of pathophysiological events, attenuating the brain damage. Inhibition of this protective effect by SR-141716A, a CB1 cannabinoid receptor antagonist, and the lack of effect of 2-AG in CB1 knockout mice suggest that 2-AG and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 74 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 50 references

a drug discovery perspective

  • Piomelli D The endocannabinoid system
  • Curr Opin Investig Drugs 6:622–679 74 Mol…
  • 2007

Similar Papers

Loading similar papers…